Trademark Alertz ®
Search
Trademark
Owner
Trademark: AKOUOS 2178795
Word
AKOUOS
Device Descrption:
WAVY STRIPE DIVIDES WORD
ID
2178795
Trademark Type
Figurative
Status
Registered: Registered/protected
Application Date
13 May 2021
Registration Date
13 May 2021
Renewal Date
13 May 2031
Owner(s)
Akouos, Inc.
Service
McCullough Robertson Lawyers
Goods and Services:
Class 5
:
Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
;
biologics and small molecules in the nature of pharmaceutical preparations for use in treating diseases and conditions involving the ear in the nature of genetic conditions causing hearing loss
;
gene therapy products to restore, improve, and preserve hearing
;
gene therapy products to treat inner ear disorders and conditions
;
viral vectors, non-viral vectors, gene therapy vectors all for medical purposes in gene therapy for inner ear disorders and conditions
;
biotechnological platform technology, namely, biological nanoparticles and adenoviruses for gene delivery to biological cells that includes adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to restore, improve and preserve hearing
;
biotechnological platform technology, namely, biological nanoparticles and adenoviruses for gene delivery to biological cells that includes adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to treat inner ear disorders and conditions
Class 10
:
Drug delivery systems
;
viral vector delivery platforms for gene therapy
;
medical devices for use in treating diseases and conditions involving the ear in the nature of genetic conditions causing hearing loss
Class 41
:
Providing education information regarding inner ear disorders and conditions, hearing loss and genetics via a website
Class 42
:
Scientific research consulting in the field of inner ear disorders and conditions and hearing loss
;
custom development of biochemical reagents and biological nanoparticles, namely, therapeutic compositions that include adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to restore, improve and preserve hearing
;
custom development of biochemical reagents and biological nanoparticles, namely, therapeutic compositions that include adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy to treat inner ear disorders and conditions